OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management GmbH sold 78,795 shares of OraSure Technologies, reducing its holdings by 9.8%, and now owns 726,895 shares valued at approximately $2.45 million.
• OraSure Technologies saw its stock price decrease by 2.4% recently, with a current market cap of $244.60 million and a 52-week trading range between $2.36 and $4.92.
• Research analysts have upgraded OraSure Technologies from a "sell" to a "hold" rating, with Evercore ISI setting a price objective of $3.00 for the stock.

Allianz Asset Management GmbH lessened its stake in OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 9.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 726,895 shares of the medical instruments supplier's stock after selling 78,795 shares during the quarter. Allianz Asset Management GmbH owned about 0.94% of OraSure Technologies worth $2,450,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Tower Research Capital LLC TRC grew its position in shares of OraSure Technologies by 202.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 5,234 shares during the period. Causeway Capital Management LLC purchased a new stake in shares of OraSure Technologies in the fourth quarter valued at about $36,000. Raymond James Financial Inc. purchased a new position in OraSure Technologies in the fourth quarter worth $37,000. Boothbay Fund Management LLC bought a new stake in OraSure Technologies in the fourth quarter worth about $42,000. Finally, Gotham Asset Management LLC purchased a new position in OraSure Technologies in the fourth quarter valued at approximately $43,000. Institutional investors own 93.50% of the company's stock.

OraSure Technologies Trading Down 5.3%

Shares of OraSure Technologies stock traded down $0.17 on Friday, hitting $3.01. 928,277 shares of the company traded hands, compared to its average volume of 779,767. OraSure Technologies, Inc. has a 52 week low of $2.36 and a 52 week high of $4.92. The stock's 50 day moving average price is $3.02 and its 200-day moving average price is $3.24. The company has a market cap of $225.15 million, a PE ratio of -7.17 and a beta of 0.45.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of OraSure Technologies from a "sell" rating to a "hold" rating in a research report on Saturday, May 17th. Evercore ISI reaffirmed an "in-line" rating and issued a $3.00 target price on shares of OraSure Technologies in a report on Monday, May 19th.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.